Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New HHS Chief Alex Azar Supports LDT Regulation, Cost-Saving Bundles

Executive Summary

Alex Azar was confirmed as the next secretary of Health and Human Services with strong industry support. Azar comes to the role with some homework to do on key FDA medtech policies, but has expressed support for risk-based regulation of lab-developed tests and cost-saving bundled-payment models.

Advertisement

Related Content

HHS Chief Scores With Congress On DME Bid Program, Telehealth Pay, But Says LDTs Complex
Gaps In Quality Measures Could Lead To Loss In Device Product Access, White Paper Says
US FDA Chief Favors LDT Approach In Bucshon-DeGette Bill
AdvaMed CEO Supports Potential HHS Secretary Nominee Azar
Lack Of Device Identifiers On Recalled Cardiac Devices Cost Medicare $1.5Bn, OIG Says
NEST Executive Director: A One Woman Army

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

MT122096

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel